总部位于巴黎的生物技术公司Aqemia近日宣布，已完成3000万欧元的A轮追加融资，使得本轮融资总额达到6000万欧元。Aqemia利用生成式AI和量子技术加速药物发现和设计，其人工智能驱动技术能够快速识别和设计对抗不同疾病的潜在药物分子。本轮融资的领投方为Wendel Growth，其他参投方包括法国VC Eurazeo和公共银行Bpifrance、Elaia。
Title: Aqemia Secures €30 Million in Series A Follow-on Funding
Keywords: Aqemia, Series A Funding, Biotechnology
News content:
Paris-based biotech company Aqemia has recently announced the completion of a €30 million Series A follow-on funding round, bringing the total equity financing for this round to €60 million. Aqemia utilizes generative AI and quantum technology to accelerate drug discovery and design, and its AI-driven technology can rapidly identify and design potential drug molecules to combat various diseases. The round was led by Wendel Growth, with other participating investors including French VC Eurazeo and public bank Bpifrance, Elaia.
【来源】https://sifted.eu/articles/aqemia-60m-series-a
Views: 1